Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Protech Home Medical Announces Date and Time for Quarterly Conference Call

T.QIPT

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.

CINCINNATI, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company”) (TSXV:PHM), a healthcare services company with operations in the U.S., today announced that it will host its Quarterly Conference Call on Tuesday, August 28, 2018 at 4:00 p.m. (EDT).

Conference Call Details:

Tuesday, August 28, 2018 at 4:00 p.m. (EDT).

US Toll Free: 866-519-2796
Canada Toll Free: +1-647- 484-0476
Participant Passcode: 582338

In addition, the board of directors of the Company has approved the grant of 1,000,000 stock options, expiring in 10 years, to Mr. D. Eugene Ewing at an exercise price of $0.11 pursuant to the Company's fixed number stock option plan.

ABOUT PROTECH HOME MEDICAL

The Company provides in-home monitoring and disease management services for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The initial service line includes providing in-home monitoring equipment, supplies and services to patients in the U.S. who take prescription blood thinners, such as Coumadin® (warfarin).

The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information please visit our website at www.phmcompanies.com, or contact:

Greg Crawford
CEO/Chairman
Protech Home Medical Corp.
859-300-6455
investorinfo@myphm.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today